| Citation: | WANG Ling-ling, ZHANG Yong-wen. Discussions on the Quality Controls of Chinese Herbal Decoction Pieces Based on Requirements for Drug Technical Evaluation[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(2): 166-171. doi: 10.14148/j.issn.1672-0482.2022.0166
|
| [1] |
陈钰婷, 孙树周, 温颖婉, 等. 浅议我国地方中药饮片炮制规范的执行策略[J]. 中国食品药品监管, 2021(1): 65-74. https://www.cnki.com.cn/Article/CJFDTOTAL-YPJD202101009.htm
CHEN YT, SUN SZ, WEN YW, et al. Discussion of the implementation strategy of local processing standards for TCM decoction pieces in China[J]. China Food Drug Adm Mag, 2021(1): 65-74. https://www.cnki.com.cn/Article/CJFDTOTAL-YPJD202101009.htm
|
| [2] |
国家食品药品检定研究院. 2016年国家药品抽检年报[EB/OL]. (2017-10-09)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/20171009132201938.html.
National Institute for Food and Drug Control. 2016 annual report on the spot check of national drug[EB/OL]. (2017-10-09)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/20171009132201938.html.
|
| [3] |
国家食品药品检定研究院. 2017年国家药品抽检年报[EB/OL]. (2018-06-05)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/20180605132401655.html.
National Institute for Food and Drug Control. 2017 annual report on the spot check of national drug[EB/OL]. (2018-06-05)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/20180605132401655.html.
|
| [4] |
国家食品药品检定研究院. 2018年国家药品抽检年报[EB/OL]. (2019-08-07)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/20190807102557426.html.
National Institute for Food and Drug Control. 2018 annual report on the spot check of national drug[EB/OL]. (2019-08-07)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/2019 0807102557426.html.
|
| [5] |
国家食品药品检定研究院. 2019年国家药品抽检年报[EB/OL]. (2020-03-23)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/20200323143900758.html.
National Institute for Food and Drug Control. 2019 annual report on the spot check of national drug[EB/OL]. (2020-03-23)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/20200323143900758.html.
|
| [6] |
国家食品药品检定研究院. 2020年国家药品抽检年报[EB/OL]. (2021-03-23)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/gjchjtzgg/202103231108143186.html.
National Institute for Food and Drug Control. 2020 annual report on the spot check of national drug[EB/OL]. (2021-03-23)[2021-09-15]. https://www.nifdc.org.cn//nifdc/bshff/gjchj/gjchjtzgg/202103231108143186.html.
|
| [7] |
王玲玲, 周跃华, 李计萍, 等. 关于中药新药用饮片炮制研究的思考[J]. 中草药, 2021, 52(1): 9-13. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202101003.htm
WANG LL, ZHOU YH, LI JP, et al. Thoughts on research of processing of Chinese herbal pieces for new drugs of Chinese medicine[J]. Chin Tradit Herb Drugs, 2021, 52(1): 9-13. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202101003.htm
|
| [8] |
杨明翰, 梁政亭, 盛萍. 新疆民族药的开发研究与前景展望[J]. 中国实验方剂学杂志, 2021, 27(17): 227-236. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202117033.htm
YANG MH, LIANG ZT, SHENG P. Xinjiang ethnic medicines: A review[J]. Chin J Exp Tradit Med Formulae, 2021, 27(17): 227-236. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202117033.htm
|
| [9] |
钟国跃, 王昌华, 赵纪峰, 等. 民族药资源研究思路与中药资源的可持续利用[J]. 世界科学技术-中医药现代化, 2009, 11(1): 15-20. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX200901008.htm
ZHONG GY, WANG CH, ZHAO JF, et al. Methods for studying national medicinal resources and sustainable utilization of TCM resources[J]. World Sci Technol Mod Tradit Chin Med Mater Med, 2009, 11(1): 15-20. https://www.cnki.com.cn/Article/CJFDTOTAL-SJKX200901008.htm
|
| [10] |
黎耀东, 付淑媛, 何江, 等. 新疆特有药用植物新疆阿魏资源现状与分析[J]. 中国现代中药, 2016, 18(6): 714-717. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX201606009.htm
LI YD, FU SY, HE J, et al. Analysis of specific medicinal plants resources Ferula sinkiangensis in Xinjiang[J]. Mod Chin Med, 2016, 18(6): 714-717. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX201606009.htm
|
| [11] |
高雯雯, 肖凡, 苏婧怡, 等. 新疆野巴旦杏的资源现状和发展趋势分析[J]. 特种经济动植物, 2020, 23(8): 47-48. https://www.cnki.com.cn/Article/CJFDTOTAL-TZJD202008020.htm
GAO WW, XIAO F, SU JY, et al. Analysis of the current resource status and development trend of wild amygdalus communis in Xinjiang[J]. Spec Econ Animal Plant, 2020, 23(8): 47-48. https://www.cnki.com.cn/Article/CJFDTOTAL-TZJD202008020.htm
|
| [12] |
罗青红, 宁虎森, 刘永萍, 等. 新疆罗布麻和甘草资源现状分析与评价[J]. 防护林科技, 2019(5): 13-16. https://www.cnki.com.cn/Article/CJFDTOTAL-FHLK201905004.htm
LUO QH, Ning HS, LIU YP, et al. Analysisi and Evaluation of Resource Status of Apocynum venetum and Glycyrrhiza uralensis in Xinjiang Uygur Autonomous Region[J]. Protect For Sci Technol, 2019(5): 13-16. https://www.cnki.com.cn/Article/CJFDTOTAL-FHLK201905004.htm
|
| [13] |
国家药品监督管理局. 国家药品监督管理局关于发布《中药注册分类及申报资料要求》的通告(2020年第68号)[EB/OL]. (2020-09-28)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20200928164311143.html.
National Medical Products Administration. Notice on the publication of the "Registration classification of Chinese medicine and declared data requirements" (No. 68, 2020)[EB/OL]. (2020-09-28)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20200928164311143.html.
|
| [14] |
王玲玲, 胡流芳, 张晓东, 等. 2005—2020年申请临床试验中药新药的审评审批情况分析[J]. 中草药, 2021, 52(12): 3765-3774. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202112034.htm
WANG LL, HU LF, ZHANG XD, et al. Analysis on approval of new Chinese medicine applied for investigational new drug from 2005 to 2020[J]. Chin Tradit Herb Drugs, 2021, 52(12): 3765-3774. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202112034.htm
|
| [15] |
国家药品监督管理局. 国家药监局药审中心关于发布《中药新药研究各阶段药学研究技术指导原则(试行)》的通告(2020年第37号)[EB/OL]. (2020-11-04)[2021-09-15]. http://www.cde.org.cn/news.do?method=largeInfo&id=9492b31440407527.
National Medical Products Administration. Notice of the center for food and drug inspection of NMPA on the publication of the "Technical guidelines for pharmacological research in all phases of new drug of Chinese medicine (trial implementation)" (No. 37, 2020)[EB/OL]. (2020-11-04)[2021-09-15]. http://www.cde.org.cn/news.do?method=largeInfo&id=9492b31440407527.
|
| [16] |
国家药品监督管理局. 国家食品药品监督管理局关于印发《天然药物新药研究技术要求》的通知(国食药监注〔2013〕17号)[EB/OL]. (2013-01-18)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20130118120001687.html.
National Medical Products Administration. Posted on the publication of the "Technical requirements for new drug research on natural drugs" (State Food and Drug Administration Note〔2013〕No. 17)[EB/OL]. (2013-01-18)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20130118120001687.html.
|
| [17] |
国家药品监督管理局. 国家药监局药审中心关于发布《中药新药用药材质量控制研究技术指导原则(试行)》等3个指导原则的通告(2020年第31号)[EB/OL]. (2020-10-12)[2021-09-15]. http://www.cde.org.cn/news.do?method=viewInfoCommon&id=8f11f5ed03d3ef1d.
National Medical Products Administration. Notice of the center for food and drug inspection of NMPA on the publication of the "Technical guidelines for quality control research of medicinal materials for new Chinese medicines (trial implementation) and other three guidelines (No. 31, 2020)[EB/OL]. (2020-10-12)[2021-09-15]. http://www.cde.org.cn/news.do?method=viewInfoCommon&id=8f11f5ed03d3ef1d.
|
| [18] |
国家药品监督管理局. 国家药监局药审中心关于发布《按古代经典名方目录管理的中药复方制剂药学研究技术指导原则(试行)》意见的通知[EB/OL]. (2021-08-31)[2021-09-15]. http://www.cde.org.cn/news.do?method=viewInfoCommon&id=eb1ece6c367ee461.
National Medical Products Administration. Notice of the center for food and drug inspection of NMPA on the publication of the "Technical guidelines for the pharmacological study of research on Chinese medicine compound preparations managed according to the ancient classical prescription catalog (trial implementation)"[EB/OL]. (2021-08-31)[2021-09-15]. http://www.cde.org.cn/news.do?method=viewInfoCommon&id=eb1ece6c367ee461.
|
| [19] |
国家药品监督管理局. 国家药品监督管理局关于发布《中药、天然药物改变剂型研究技术指导原则》的通告(2014年第1号)[EB/OL]. (2014-03-07)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20140307120001463.html.
National Medical Products Administration. Posted on the notice of "Technical guidelines of the research on dosage form change on Chinese medicine, natural drugs" (No. 1, 2014)[EB/OL]. (2014-03-07)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20140307120001463.html.
|
| [20] |
国家药品监督管理局. 关于中成药处方中使用天然麝香、人工麝香有关事宜的通知(国食药监注〔2005〕353号)[EB/OL]. (2005-07-05)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20050705010101676.html.
National Medical Products Administration. Notice on matters related to the use of natural musk and artificial musk in the prescription of Chinese patent medicines (National food and drug administration note[2005] No. 353)[EB/OL]. (2005-07-05)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20050705010101676.html.
|
| [21] |
国家药品监督管理局. 关于加强含牛黄等药材中成药品种监督管理的通知(国食药监注〔2012〕355号)[EB/OL]. (2012-12-05)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20121205120001275.html.
National Medical Products Administration. Notice on strengthening the supervision and management of varieties of Chinese patent medicines containing calculus bovis (National food and drug administration note〔2012〕 No. 355)[EB/OL]. (2012-12-05)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20121205120001275.html.
|
| [22] |
国家药品监督管理局. 关于征求进一步加强含麝香等药材中成药品种监督管理意见的通知(食药监办注函〔2012〕67号)[EB/OL]. (2012-02-20)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20120220120001213.html.
National Medical Products Administration. Notice on the solicitation of further strengthening the supervision and management of varieties of Chinese patent medicines containing musk (Food and drug administration office note letter〔2012〕 No. 67)[EB/OL]. (2012-02-20)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20120220120001213.html.
|
| [23] |
国家林业局. 关于加强赛加羚羊、穿山甲、稀有蛇类资源保护和规范其产品入药管理的通知(林护发〔2007〕242号)[EB/OL]. (2007-11-12)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/qita/20071112120001904.html.
State Forestry Administration. Notice on strengthening the protection of saiga tatarica, pangolin, and rare snake and regulating the management of their products as medicine (Forest protection announcement〔2007〕 No. 242)[EB/OL]. (2007-11-12)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/qita/20071112120001904.html.
|
| [24] |
王玲玲, 王曙, 曲建博, 等. 含贝母药材的中药制剂质量控制研究的思考[J]. 中草药, 2021, 52(11): 3462-3466. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202111034.htm
WANG LL, WANG S, QU JB, et al. Consideration of quality control of traditional Chinese medicine preparations containing fritillaria[J]. Chin Tradit Herb Drug, 2021, 52(11): 3462-3466. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO202111034.htm
|
| [25] |
国家药品监督管理局. 关于促进中药传承创新发展的实施意见(国药监药注〔2020〕27号)[EB/OL]. (2020-12-25)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20201225163906151.html.
National Medical Products Administration. Implementation opinions on promoting the development of traditional Chinese medicine inheritance and innovation (State Drug Administration Drug Note〔2020〕 No. 27)[EB/OL]. (2020-12-25)[2021-09-15]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20201225163906151.html.
|
| [26] |
中华人民共和国濒危物种科学委员会. 关于发布濒危野生动植物种国际贸易公约中文版(国家濒管办公告2019年第5号)[EB/OL]. (2019-11-25)[2021-09-15]. http://www.cites.org.cn/citesgy/wb/.
Endangered Species Scientific Commission, P.R. China. Posted on the Chinese version of the convention on international trade in endangered species of wild fauna and flora (National endangered management office announcement No. 5, 2019)[EB/OL]. (2019-11-25)[2021-09-15]. http://www.cites.org.cn/citesgy/wb/.
|
| [27] |
国家林业和草原局. 国家林业和草原局农业农村部公告(2021年第15号)(国家重点保护野生植物名录)[EB/OL]. (2021-09-08)[2021-09-15]. http://www.forestry.gov.cn/main/5461/20210908/162515850572900.html.
National Forestry and Grassland Administration. Ministry of agriculture and rural affairs announcement (No. 15, 2021) (National key protected wild plants list)[EB/OL]. (2021-09-08)[2021-09-15]. http://www.forestry.gov.cn/main/5461/20210908/162515850572900.html.
|
Copyright © Journal of Nanjing University of traditional Chinese Medicine
Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023
Tel：025-85811935Email：xb@njucm.edu.cn
Supported by:
Beijing Renhe Information Technology Co., Ltd.
DownLoad: